Disulfiram-associated hypercholesterolemia

E. L. Rogers, S. M. Naseem

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The rat model is used to verify disulfiram-associated hypercholesterolemia and to determine a mechanism of action. Administration of disulfiram 15 mg/kg/day for 3 wk is associated with a 25% increase in serum cholesterol which is reversible with discontinuance of the drug. The hypercholesterolemia is due in part to a fourfold increase in activity of hepatic HMG-CoA reductase, the rate-limiting step in cholesterol biosyntheses.

Original languageEnglish (US)
Pages (from-to)75-77
Number of pages3
JournalAlcoholism: Clinical and Experimental Research
Volume5
Issue number1
StatePublished - 1981
Externally publishedYes

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology

Fingerprint

Dive into the research topics of 'Disulfiram-associated hypercholesterolemia'. Together they form a unique fingerprint.

Cite this